National Comprehensive Cancer Network

Educational Events & Programs

NCCN 7^th Annual Congress:
Hematologic Malignancies™

Save the Date!

September 14 - 15, 2012

New York Marriott^® Marquis
New York, New York

Overview

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This Congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Please check back often for the most up-to-date information.

Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Director, Marketing.

NCCN Annual Congress Sponsorship

NCCN Annual Congress Exhibit Application

Select sessions from the NCCN 6^th Annual Congress: Hematologic Malignancies™ are available on QuantiaMD:

Treatment Options for Bortezomib/Lenalidomide Refractory Multiple Myeloma

Maintenance Therapy in Follicular Lymphoma: Yes, No, or Maybe?